JE

Joycelyn Entwistle

VB Viventia Bio: 3 patents #4 of 10Top 40%
Merck: 3 patents #3,073 of 9,382Top 35%
VB Viventia Biotechnologies: 2 patents #4 of 7Top 60%
NC National Research Council Of Canada: 1 patents #547 of 1,315Top 45%
📍 Cross Lake, CA: #9 of 191 inventorsTop 5%
Overall (All Time): #571,758 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
9822182 Anti-EPCAM antibodies and methods of use Jeannick Cizeau, Arjune Premsukh, Shilpa Chooniedass, Glen MacDonald 2017-11-21
8969540 Tumor specific antibody Nicholas Ronald Glover, Glen MacDonald, Jeannick Cizeau, Denis Georges Bosc, Francina C. Chahal 2015-03-03
8716234 Cytotoxins comprising modified bouganin toxin for the treatment of cancer Matthew Baker, Francis Joseph Carr, Koen Hellendoorn, Jeannick Cizeau, Glen MacDonald +2 more 2014-05-06
8697075 Cancer specific antibody and cell surface proteins Nicholas Ronald Glover, Glen MacDonald, Jeannick Cizeau, Francina C. Chahal 2014-04-15
8383117 CD44E tumor specific antibody Nicholas Ronald Glover, Glen MacDonald, Jeannick Cizeau, Denis Georges Bosc, Francina C. Chahal 2013-02-26
8372954 Phage display libraries of human VH fragments Jamshid Tanha, Saran Narang, Michael Dan, Colin Roger Mackenzie, Howard Kaplan 2013-02-12
8084576 Cancer associated glucose transporter 8 variant Nicholas Ronald Glover, Glen MacDonald, Jeannick Cizeau, Francina C. Chahal 2011-12-27
7750136 Modified bouganin proteins, cytotoxins and methods and uses thereof Matthew Baker, Francis Joseph Carr, Koen Hellendoorn, Jeannick Cizeau, Glen MacDonald +2 more 2010-07-06
7339031 Modified bouganin proteins, cytotoxins and methods and uses thereof Matthew Baker, Francis Joseph Carr, Koen Hellendoorn, Jeannick Cizeau, Glen MacDonald +2 more 2008-03-04